EVENTIDE
Eventide Asset Management, LLC is a Boston-based investment adviser practicing "investing that makes the world rejoice®." Founded in 2008, Eventide's vision is to serve individuals, financial advisors, and institutions by providing high-performance investments that we believe create compelling value for the global common good.
EVENTIDE
Social Links:
Industry:
Financial Services
Founded:
2008-01-01
Status:
Active
Contact:
877-771-3836
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Tag Manager Google Universal Analytics Global Site Tag IPv6 Google Apps For Business GoDaddy DNS HubSpot CMS Hub Fastly Hosted Fastly Load Balancer
Similar Organizations
Block Dream Fund
Block Dream Fund operates as an investment institution.
Clocktower Technology Ventures
Clocktower Technology Ventures invests in the insurance, payments, personal finance, lending, credit, and asset management sectors.
Alpha Wave Global
Alpha Wave Global provides asset classes, themes, and geographies from venture capital to public markets to credit.
Fidelity Management and Research Company
Fidelity Management and Research Company is a privately-owned investment manager.
J.P. Morgan Asset Management
J.P. Morgan Asset Management is an asset manager for individuals, advisors, and institutions.
Janus Henderson Investors
Janus Henderson Investors is an asset manager that helps their clients achieve their financial goals.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-17 | Beta Bionics | Eventide investment in Series C - Beta Bionics | 57 M USD |
| 2022-01-25 | Metagenomi | Eventide investment in Series B - Metagenomi | 175 M USD |
| 2022-01-05 | Korro Bio | Eventide investment in Series B - Korro Bio | 116 M USD |
| 2021-12-07 | Freenome | Eventide investment in Series D - Freenome | 300 M USD |
| 2021-11-02 | Shoreline Biosciences | Eventide investment in Series B - Shoreline Biosciences | 140 M USD |
| 2021-10-01 | Roivant Sciences | Eventide investment in Post-IPO Equity - Roivant Sciences | 200 M USD |
| 2021-09-09 | LEXEO Therapeutics | Eventide investment in Series B - LEXEO Therapeutics | 100 M USD |
| 2021-08-24 | Dice Therapeutics | Eventide investment in Series C - Dice Therapeutics | 60 M USD |
| 2021-07-14 | Turnstone Biologics | Eventide investment in Series D - Turnstone Biologics | 80 M USD |
| 2021-06-09 | Kojin Therapeutics | Eventide investment in Series A - Kojin Therapeutics | 60 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-03 | Eventide Asset Management Announces Promotion of Dolores Bamford to Co-Chief Investment Officer |